nCPAP Versus High-Flow Nasal Cannula in Preterm Infants With RDS
Comparison Between the Use of nCPAP and High-Flow Nasal Cannula in Preterm Infants With Respiratory Distress Syndrome in the NICU
1 other identifier
interventional
94
0 countries
N/A
Brief Summary
This randomized controlled trial aims to compare the efficacy and safety of nasal continuous positive airway pressure versus high-flow nasal cannula as initial non-invasive respiratory support in preterm infants with respiratory distress syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2026
CompletedFirst Posted
Study publicly available on registry
October 9, 2026
CompletedStudy Start
First participant enrolled
October 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 25, 2028
October 9, 2026
October 1, 2026
1 year
October 6, 2026
October 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment failure within 72 hours
Number of infants meeting predefined criteria for treatment failure of the assigned non-invasive respiratory support modality within the first 72 hours.
At 72 hours
Secondary Outcomes (5)
Need for mechanical ventilation
At 72 hours
Need for surfactant therapy
At 72 hours
Duration of respiratory support
At 28 days
Incidence of nasal trauma
At 28 days
Incidence of pneumothorax
At 28 days
Study Arms (2)
Nasal Continuous Positive Airway Pressure
EXPERIMENTALPreterm infants will receive nasal continuous positive airway pressure through an appropriate neonatal interface.
High-Flow Nasal Cannula
ACTIVE COMPARATORPreterm infants will receive heated and humidified high-flow nasal cannula therapy.
Interventions
Non-invasive respiratory support using either nCPAP or high-flow nasal cannula according to group allocation.
Eligibility Criteria
You may qualify if:
- \- Preterm infants with gestational age 28 to 36 weeks and 6 days
- Clinical diagnosis of respiratory distress syndrome
- Spontaneous breathing without immediate need for invasive mechanical ventilation
- Requirement for non-invasive respiratory support
- Written informed consent from parent or legal guardian
You may not qualify if:
- \- Infants requiring immediate endotracheal intubation and mechanical ventilation
- Major congenital anomalies affecting the respiratory or cardiovascular systems
- Congenital diaphragmatic hernia
- Significant congenital heart disease
- Severe perinatal asphyxia requiring prolonged resuscitation
- Severe hemodynamic instability
- Prolonged mechanical ventilation before enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hekma S Farghaly, prof
Pediatrics Department, Assiut University Hospitals
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician, Department of Pediatrics
Study Record Dates
First Submitted
October 6, 2026
First Posted
October 9, 2026
Study Start
October 10, 2026
Primary Completion (Estimated)
October 10, 2027
Study Completion (Estimated)
February 25, 2028
Last Updated
October 9, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share